(Q70118165)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

Patricia Van der Niepen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

A G Dupont

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J J Smitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

R O Six

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

207-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00547423

8 October 2019

exact match

0 references

cites work

Dopaminergic inhibition of aldosterone secretion in man is independent of the autonomic nervous system

1 reference

12 December 2020

Bromocriptine-induced modulation of plasma aldosterone response to acute stimulations

1 reference

12 December 2020

Inhibition of the plasma-aldosterone response to frusemide by bromocriptine

1 reference

12 December 2020

Renal-Adrenal Inter-Relationships

1 reference

12 December 2020

Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney

1 reference

12 December 2020

Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes

1 reference

12 December 2020

Metoclopramide increases plasma aldosterone concentration in man

1 reference

12 December 2020

Dopaminergic modulation of renin release

1 reference

12 December 2020

Stimulation of aldosterone secretion by metoclopramide in humans: Apparent independence of renal and pituitary mediation

1 reference

12 December 2020

Dopamine modulates sodium-dependent aldosterone responses to angiotensin II in humans

1 reference

12 December 2020

Tonic dopaminergic suppression of plasma aldosterone

1 reference

12 December 2020

Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat

1 reference

12 December 2020

Dopaminergic control of serum potassium

1 reference

12 December 2020

Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man

1 reference

12 December 2020

Effect of L-dopa and bilateral nephrectomy on the aldosterone response to metoclopramide

1 reference

12 December 2020

Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone

1 reference

12 December 2020

Metoclopramide. An updated review of its pharmacological properties and clinical use.

1 reference

12 December 2020

Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat

1 reference

12 December 2020

Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine

1 reference

12 December 2020

The other angiotensins

1 reference

12 December 2020

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

1 reference

12 December 2020

Dopaminergic modulation of aldosterone secretion is independent of alterations in renin secretion

1 reference

12 December 2020

Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications

1 reference

12 December 2020

Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421)

1 reference

12 December 2020

Peripheral dopamine receptor identification: properties of a specific dopamine receptor in the rat adrenal zona glomerulosa

1 reference

12 December 2020

Effect of metoclopramide on aldosterone and regulatory factors in man

1 reference

12 December 2020

Characterization of dopamine receptors by 3H-ADTN binding in calf adrenal zona glomerulosa

1 reference

12 December 2020

Dopaminergic Control of Plasma Catecholamine and Aldosterone Responses to Acute Stimuli in Normal Man

1 reference

12 December 2020

Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade

1 reference

12 December 2020

Dopaminergic modulation of 18-hydroxycorticosterone secretion in man

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00547423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000795%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference